Polaryx Therapeutics Inc.

Last updated September 27, 2026

Organization details

Legal name
Polaryx Therapeutics Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Wyoming
Headquarters city
Paramus
Headquarters state / province
New Jersey
Headquarters country
United States
Fiscal year end
December
Ticker symbol
PLYX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0002075320

Board of directors

Chief executives

Alex Keun Mo Yang · Chief Executive Officer
Since January 2026

Director election results

Annual meeting of September 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

1 of this board's directors also sit on 3 other boards.

Network of Polaryx Therapeutics Inc.'s board connections Elite Express Holding Inc. Elite Express Holding... ITG Inc. ITG Inc. SHF Holdings Inc. SHF Holdings Inc. Iii Francis A. Braun Iii Francis A. Braun Polaryx Therapeutics Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$368,003
2 purchases by 2 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
May 27, 2026 Mstone Partners Healthcare Ltd Director, 10% owner Open-market purchase +88,453 $4.07 $360,004
Feb 18, 2026 G. Michael Landis Director, Officer (Chief Financial Officer) Open-market purchase +2,867 $2.79 $7,999

Organizations in the same sector, closest in location and size first.

Questions about Polaryx Therapeutics Inc.

Who is the CEO of Polaryx Therapeutics Inc.?

Alex Keun Mo Yang has been Polaryx Therapeutics Inc.'s Chief Executive Officer since January 2026.

How many directors are on Polaryx Therapeutics Inc.'s board?

Polaryx Therapeutics Inc.'s board has 5 directors: Alex Keun Mo Yang, Charles S. Ryan, G. Michael Landis, Iii Francis A. Braun and Mitchel Berger.

Are Polaryx Therapeutics Inc. insiders buying or selling shares?

Over the last 12 months, Polaryx Therapeutics Inc. insiders bought $368,003 of shares in 2 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="polaryx-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.